On February 25th, 2022, the Company conducted a Continuing Public Offering of Obligasi Berkelanjutan I Pyridam Farma Tahap I Year 2022 with a Principal Amount of Rp.400,000,000,000. The target of the Sustainable Bond Funds raised is Rp.1,200,000,000,000.

In July 2022, the Company has carried out the acquisition of all shares of the company PT Ethica Industri Farmasi (PT EIF). The Company’s share ownership in PT EIF directly becomes 99.99% and indirectly becomes 100% through the ownership of shares in PT EIF by PT PSI of 0.01%. In addition, PT PSI has also completed a transaction to acquire shares of Indopacific Health Technology Pte. Ltd. a limited liability company established under the laws of Singapore (“IHT”) which resulted in PSI owning 6.76% of the issued and paid-up capital in IHT.